Publication | Closed Access

Development of pyridazine derivatives as potential EGFR inhibitors and apoptosis inducers: Design, synthesis, anticancer evaluation, and molecular modeling studies

Medicinal ChemistryPyridazine DerivativesPotential Egfr InhibitorsMedicineRational Drug DesignAnticancer EvaluationPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryTumor BiologyDrug Discovery